Tilray, Inc. (TLRY)

48.97
NASDAQ
Prev Close 48.97
Day Low/High 0.00 / 0.00
52 Wk Low/High 20.10 / 300.00
Exchange NASDAQ
Shares Outstanding 96.79B
Market Cap 4.74B
Div & Yield N.A. (N.A)
Red-Hot Tilray Morphs Into Game of Trading Other Traders, Not the Stock

Red-Hot Tilray Morphs Into Game of Trading Other Traders, Not the Stock

At some point Tilray is going to suffer a very ugly drop, but trying to guess when is like trying to time a slot machine.

Tilray Foolishness

"The problem with the world is that fools and fanatics are always so certain of themselves and wiser people so full of doubts." -- Bertrand Russell  The interest rate for a Tilray borrow is now over 264% -- that's annually! Be forewarned.

Tilray Surges Over 50% Wednesday Morning, Punishing Short-Sellers

Tilray Surges Over 50% Wednesday Morning, Punishing Short-Sellers

The cannabis company has gained DEA approval to import a cannabinoid drug into the U.S.

Another Short-Selling Lesson (Part Deux)

* Tilray is now a sideshow of classic speculative activity * Neither go short nor go long TLRY * Ignore TLRY and move on Pot stock Tilray, Inc. is trading at $215/share (+$60 in premarket trading).  The short squeeze is reminiscent of Robert Wilson'...

Cannabis Craziness

Experts Are High on Cannabis Stocks' 2019 Prospects

Experts Are High on Cannabis Stocks' 2019 Prospects

Expect more companies to join Coca-Cola, Molson Coors and Constellation Brands in checking out the market.

What's a Weary Market Bear to Do?

What's a Weary Market Bear to Do?

This is an ideal setup for a short squeeze.

FedEx's Report Was Soft, but the Guidance Isn't Bad

FedEx's Report Was Soft, but the Guidance Isn't Bad

It is likely that value buyers will be looking for entry soon as the stock tests the $240 area.

Coke's Flirtation with Cannabis Reaffirms What We Already Know

Coke's Flirtation with Cannabis Reaffirms What We Already Know

The latest reports about Coke looking into cannabis confirms a broader industry trend.

Losing Trades Are a Sign of Superior Trading

Losing Trades Are a Sign of Superior Trading

If you don't have a steady diet of losing trades you probably aren't trading at optimal levels.

Bulletproof Market Shrugs Off the Negatives

Bulletproof Market Shrugs Off the Negatives

Wild speculation in pot stocks and IPO names was a notable characteristic this week.

The Bullish Bias Resounds

This morning the futures (S&P and Nasdaq) are, as is the custom, higher. The markets continue to ignore a number of cautionary signposts/macroeconomic events/concerns and are benefiting from the float shrink of 5-7 years of corporate share buybacks,...

Tilray: The Trading Equivalent of a Ponzi Scheme

Tilray: The Trading Equivalent of a Ponzi Scheme

The pot stock is up some 500% even though probably everyone knows it's not worth that much.

Another Short Selling Lesson

Pot stock Tilray, Inc. is trading at $123/share (+$19 on the day). The short squeeze is reminiscent of Robert Wilson's legendary short in Resorts International. The price action in Resorts, Tilray, Tesla , etc., are examples of why my basic and firs...

Cannabis for Traders, Cannabis for Investors: Market Recon

Cannabis for Traders, Cannabis for Investors: Market Recon

Not every cannabis stock was strong on Wednesday. One significant Canadian name sure was though.

Vape Pen Growth Is Going to Explode

Vape Pen Growth Is Going to Explode

Here are 4 stocks to buy to invest in this trend.

Craft Your Buzz on Tilray

Craft Your Buzz on Tilray

Tilray shares have more than tripled since the middle of August.

2 Big Themes Are Driving Chaotic Market Action

2 Big Themes Are Driving Chaotic Market Action

The underlying action, particularly the weakness in the technology sector, is reason for concern.

I Have No Interest in Facebook Right Now, but Twitter Is Intriguing

I Have No Interest in Facebook Right Now, but Twitter Is Intriguing

Facebook still needs to prove to the market that it can regain operational footing.

Will Investors Be Ready to Digest All the New Cannabis Stocks?

Will Investors Be Ready to Digest All the New Cannabis Stocks?

Several cannabis companies are planning to go public this fall.

Tilray Feeds Deal-Making Speculation on Analyst Call

Tilray Feeds Deal-Making Speculation on Analyst Call

Tilray reported a 95% jump in second-quarter revenue to $9.7 million, ahead of the Wall Street estimate of $9 million, in its first earnings release since it went public on July 19.

2 Trades on AMD's Incredible Run Higher: Market Recon

2 Trades on AMD's Incredible Run Higher: Market Recon

AMD continues to surge, after significant year-over-year improvements almost everywhere.

What If Canopy Growth Is Getting Too High?

What If Canopy Growth Is Getting Too High?

This is simply a short-term thesis that the cannabis rally will cool this week.

Low Volume and Seasonality Is No Reason to Fight This Stock Market Uptrend

Low Volume and Seasonality Is No Reason to Fight This Stock Market Uptrend

Seasonality hasn't mattered in a number or years so why should light volume new highs be an issue?

Tilray Offers Test of Transitioning to Recreational Cannabis Use in Canada

Tilray Offers Test of Transitioning to Recreational Cannabis Use in Canada

The Nasdaq-listed provider of medical marijuana will compete with other firms as Canada opens itself to general adult use of marijuana this fall.

Closing Bell: LIVE MARKETS BLOG

Closing Bell: LIVE MARKETS BLOG

The company said that it has closed a $427 million funding round.

Why Pay a Premium for Estee Lauder?

Why Pay a Premium for Estee Lauder?

EL's stock is up despite a guidance cut.

Tilray Rated New Buy at Roth Capital

Cannabis Firm Tilray's Successful IPO Has Other Firms High on Going Public

Cannabis Firm Tilray's Successful IPO Has Other Firms High on Going Public

Expect several more firms to list on stock exchanges this year.